Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01127867 · ClinicalTrials.gov registry record · NA
A Pilot Study of Docosahexaenoic Acid (DHA) in Obese Menopausal Women
A NA study, sponsored by Rockefeller University.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT01127867 is a NA study that has completed, run by Rockefeller University. The registered enrollment target is 17 participants.
The verdict
NCT01127867, a NA study, has completed, sponsored by Rockefeller University.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
This study aims to determine if a supplement of an omega-3-fatty acid (docosahexaenoic - DHA) lowers inflammation in human fat tissue thereby lowering estrogen production and the potential risk for breast cancer. The investigators also aim to study how this occurs to discover the basis for other potential treatments to lower estrogen production in fat tissue and decrease the risk of breast cancer.
Interventions
- DIETARY_SUPPLEMENT dietary intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2010-05 |
| Est. Completion | 2013-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01127867
The ClinicalTrials.gov registry entry for NCT01127867 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rockefeller University, which has 117 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which dietary intervention is the first listed.
NCT01127867 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01127867 about?
NCT01127867 is a clinical study titled "A Pilot Study of Docosahexaenoic Acid (DHA) in Obese Menopausal Women". This study aims to determine if a supplement of an omega-3-fatty acid (docosahexaenoic - DHA) lowers inflammation in human fat tissue thereby lowering estrogen production and the potential risk for breast cancer. The investigators also aim to study how this occurs to discover the basis for other pot...
What is the current status of trial NCT01127867?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2010-05. Estimated completion is 2013-04.
What interventions are being tested in trial NCT01127867?
The interventions under investigation include: dietary intervention (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01127867?
This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.